The mission of the Daniella Maria Arturi Foundation (DMAF) is to stimulate and support advanced clinical and laboratory research and clinical care initiatives in Diamond Blackfan Anemia (DBA), while increasing DBA awareness among the scientific, medical, lay and government communities.  DBA is the first disease known to be associated with a defect in ribosome biosynthesis and is characterized by red cell aplasia, birth defects and a potential increased predisposition to cancer.   The coordination of these efforts aims to enhance the understanding of DBA in order to make improvements in diagnosis, treatment, and direct patient care, while working toward a cure for DBA patients around the globe.